Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
Norway
Blue Cross, Clinic Lade, Trondheim, Trøndelag Age range
18 Years – 65 Years
Last updated January 2025